ExL Pharma Announces Premier Cardiac Safety Event On May 19-20 Focusing On COX-2 Inhibitors

LIVINGSTON, N.J.--(BUSINESS WIRE)--April 8, 2005-- Speakers include Former FDA Robert R. Fenichel, MD, PhD and Jeffrey S. Borer, MD Presentations on Risk, CV Safety, Toxicity, ECG & Post-marketing Surveillance ExL Pharma announces an unprecedented industry event: Heart Attack! - An Unexpected Safety Risk, Examining COX-2 Inhibitors & Beyond taking place on May 19-20, 2005 at the Hilton East Brunswick, New Jersey. For complete conference and registration information, please visit: http://www.exlpharma.com/events.php, or call 866-247-9597. The only pharmaceutical industry event focusing on COX-2 Inhibitors, it will provide key information to help your drug development, clinical and regulatory affairs teams: